ICS Laboratories Inc. was awarded an indefinite delivery contract with a potential value of $1 million by the Centers for Disease Control and Prevention. The multiple award contract is intended to facilitate the issuance of delivery orders for post market testing of filtering facepiece respirators to evaluate safety and efficacy during public health emergencies. Under the contract, ICS Laboratories has received a $257,910 firm fixed price delivery order from the CDC to conduct post market...
Nelson Laboratories, LLC has been awarded an indefinite delivery contract from the Centers for Disease Control and Prevention with a potential value of one million dollars to provide testing and evaluation services of Federal Fire Rescue Services through September 2023. This multiple award contract has no set-aside designation. Under the contract, Nelson Laboratories will evaluate filtering facepiece respirators at its Salt Lake City facility, as detailed in a $263,820 delivery order award...
This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Homeland Security Headquarters to Intertek Testing Services NA, Inc., a foreign-owned, for-profit organization, to provide a range of quality assurance services to various federal agencies. The contract has a ceiling value of $169,359.79 and a period of performance ending on December 14, 2025. The contract includes multiple delivery orders for Intertek to conduct external audits of the Environmental and...
The Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a $118 million ceiling value to Aegis Sciences Corporation, a for-profit forensic toxicology and healthcare laboratory, to provide "TEST SURGE AND DATA SHARING" support services. Under this IDIQ, the CDC has issued two firm fixed price and time and materials task orders to Aegis. The first is a $2,427,648.50 firm fixed price task order with a period of...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Quest Diagnostics Incorporated for surge serology testing services. The contract established a potential value of $23.75 million for Quest Diagnostics to provide COVID-19 antibody testing from its Secaucus, New Jersey laboratory in support of the CDC's pandemic response. A $14 million firm fixed price delivery order to Quest Diagnostics expanded the scope of work. Under the delivery order,...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Corgenix Medical Corporation, a foreign-owned, small disadvantaged business manufacturer of goods. The $23,650,000 contract is for "SURGE SEROLOGY TESTING" services, with a period of performance from April 23, 2020 to April 22, 2021. As an IDC, this contract allows the CDC to issue task orders for serology testing services as needed. The contract does not appear to have any...
The Centers for Disease Control and Prevention awarded an indefinite delivery contract to Laboratory Corporation of America Holdings to provide surge serology testing services in support of COVID-19 response efforts. The multiple award contract has a potential value of $23.75 million and was awarded on May 7, 2020 to aid the agency through April 22, 2021. Two firm fixed price delivery orders have been issued against the contract to date. Laboratory Corporation will perform testing from its...
The Centers for Disease Control and Prevention awarded an indefinite delivery contract to Massgenics Inc., a division of Innova Solutions, Inc., with a potential value of $45 million. The contract provides for international technical, operational, and professional support services under the ITOPSS 4.0 program. A cost-plus-fixed-fee delivery order was also issued against this contract for $25,000 to support such services in Angola. The base period of performance for both the contract and first...
The Centers for Disease Control and Prevention awarded a blanket purchase agreement to Tetra Tech, Inc. to provide technical assistance services in support of the Agency for Toxic Substances and Disease Registry. With a potential value of $24,999,999.99 over five years, this multiple-award agreement enables CDC to issue task orders for metal ion and perfluorinated alkyl substances partitioning research and analysis. Under the first task order issued against this agreement, Tetra Tech will...
This Indefinite Delivery Contract is a multiple award IDIQ awarded by the Centers for Disease Control and Prevention (CDC) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The $118 million contract, with an ultimate completion date of September 5, 2029, is for "Test Surge and Data Sharing" services. Under this IDIQ, Ginkgo Bioworks is expected to provide testing and data sharing capabilities to support the CDC's public health monitoring and emergency...